Sionna Therapeutics, Inc. Common Stock (SION) — Tangible Net Worth Ratio
Sionna Therapeutics, Inc. Common Stock (SION) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($306.83 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Sionna Therapeutics, Inc. Common Stock (SION) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sionna Therapeutics, Inc. Common Stock Tangible Net Worth Ratio (2025–2025)
This chart shows how Sionna Therapeutics, Inc. Common Stock's Tangible Net Worth Ratio has changed across 1 annual periods from 2025 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $306.83 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see how much is Sionna Therapeutics, Inc. Common Stock worth.
Annual Tangible Net Worth Ratio for Sionna Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sionna Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial flexibility index of Sionna Therapeutics, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $306.83 Million | $0.00 | $325.95 Million | — |